![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 31, 29067-29071, August 3, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,From the Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115
Received for publication, April 6, 2001
| |
ABSTRACT |
|---|
|
|
|---|
All the human homologs of the six subunits of
Saccharomyces cerevisiae origin recognition complex have
been reported so far. However, not much has been reported on the nature
and the characteristics of the human origin recognition complex. In an
attempt to purify recombinant human ORC from insect cells infected with
baculoviruses expressing HsORC subunits, we found that human ORC2, -3, -4, and -5 form a core complex. HsORC1 and HsORC6 subunits did not
enter into this core complex, suggesting that the interaction of these two subunits with the core ORC2-5 complex is extremely labile. We
found that the C-terminal region of ORC2 interacts directly with the
N-terminal region of ORC3. The C-terminal region of ORC3 was, however,
necessary to bring ORC4 and ORC5 into the core complex. A fragment
containing the N-terminal 200 residues of ORC3 (ORC3N) competitively
inhibited the ORC2-ORC3 interaction. Overexpression of this fragment in
U2OS cells blocked the cells in G1, providing the first
evidence that a mammalian ORC subunit is important for the
G1-S transition in mammalian cells.
Origin recognition complex
(ORC)1 was first described in
yeast Saccharomyces cerevisiae (1). All six subunits,
essential for cell viability, collectively bind to the ARS
(autonomously replicating sequence) consensus sequence in a
sequence-specific manner and lead to the chromatin loading of other
replication factors like CDC6 and MCM (mini-chromosome maintenance)
that are essential for initiation of DNA replication (2, 3). Similar six protein complexes have been discovered in Xenopus laevis
(4), Drosophila melanogaster (5) and
Schizosaccharomyces pombe (6), although a consensus DNA
sequence that serves as an origin of replication and where ORC may bind
has not been found in these species. Conservation of similar ORC
subunits in mammals suggests that ORC has an equally important role in
mammalian cells.
Although all six human homologs of yeast S. cerevisiae ORC
subunits have been reported (7-14), purification of a six-protein human origin recognition complex remains elusive. Endogenous ORC2, -3, -4, and -5 subunits have been reported to interact with each other in
extracts of cancer cell lines (14). ORC1 and ORC6 did not interact with
other ORC subunits under these experimental conditions (14). Therefore
it is possible that a functional human ORC exists only during a very
short period of the cell cycle or in a specific sub-nuclear
compartment, making it difficult to extract such a complex from human
cell lines. In fact, in a recent study hamster ORC1 was reported to be
easily eluted from chromatin during mitosis and early G1
phase (15). It became stably bound to chromatin again during
mid-G1 phase with the appearance of a functional
pre-replication complex at a hamster replication origin. In contrast,
ORC2 was stably bound to chromatin throughout the cell cycle.
Difficulties in obtaining six protein human ORCs may also be attributed
to the fact that we are still missing some of the unidentified
important components of the human ORC. Indeed, immunoprecipitation from
[35S]methionine-labeled HeLa cell lysate of ORC1, -2, -3, -4, and -6 showed many non-ORC proteins interacting specifically with the respective ORC subunits (14, 16).
A six protein ORC has been purified from Drosophila
embryo extracts and possesses some demonstrated biochemical activities (5, 17, 18). All six Drosophila ORC subunits were expressed and subsequently purified to homogeneity from baculovirus-infected insect cells (17). Using an in vitro transcription
translation reaction, a similar six-protein ORC has been reported in
yeast S. pombe (6). With all the six human ORC subunits in
our hand, we attempted to produce recombinant human ORC from the
baculovirus expression system in order to dissect the activities and
architecture of human origin recognition complex/subcomplex(s).
Because genetic experiments are difficult to perform in mammalian
systems, the human ORC subunits have not been shown to have a role in
replication or cell proliferation. Utilizing knowledge learned about
the architecture of the human ORC, we created a dominant negative ORC
subunit designed to disrupt the formation of endogenous ORC.
Overexpression of this dominant negative ORC subunit blocked the cell
cycle in G1, providing the first evidence of the importance
of ORC in cancer cell proliferation.
Plasmid Constructions--
Cloning of ORC1-6 cDNAs are
described elsewhere (7, 9-11, 14). Coding sequences of ORC1, ORC4,
ORC5, ORC6, and ORC3N200 were cloned into pFastBac (Life Technologies,
Inc.), and coding sequences of ORC2 and ORC3 were cloned into pFastBac
Dual. ORC2, -4, and -5 were also cloned in pFB-GST vectors to express
GST fusion proteins. ORC3 and all the related constructs for in
vitro transcription and translation reactions were made into
T7T3DPAC vector (GenBankTM accession number U13871).
Full-length and C-terminal ORC2 fragments were cloned into pGEX-5X-3
(Invitrogen) to produce bacterial fusion proteins. Additional
information regarding the constructs will be made available upon request.
Expression of ORC Subunits in Insect Cells, Purification, and Gel
Filtration--
Baculoviruses were produced from the recombinant
pFastBac or pFB-GST plasmids using the Bac-to-Bac expression system
(Life Technologies, Inc.). Hi5 or Sf9 cells (Invitrogen) were
infected with these baculoviruses according to the manufacturers'
recommendations. Cells were harvested 48 h post-infection. The
cell pellet was washed once in cold phosphate-buffered saline and
subsequently resuspended in hypotonic lysis buffer (10 mM
Tris/Cl, pH 7.9, 10 mM KCl, 1.5 mM
MgCl2,1 mM phenylmethylsulfonyl fluoride, 2 µg/ml pepstatin, 2 µg/ml leupeptin, 5 µg/ml aprotinin, 1 mM dithiothreitol). The cell suspension was homogenized in
a Dounce homogenizer using a B-type pestle followed by centrifugation
at 3000 rpm for 7 min. The pellet containing the nuclei was lysed in
buffer H/0.15 (50 mM HEPES/KOH, pH 7.5, 150 mM
KCl, 0.02% Nonidet P-40, 5 mM magnesium acetate, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 2 µg/ml pepstatin, 2 µg/ml leupeptin, 5 µg/ml aprotinin, 1 mM
dithiothreitol). The resulting suspension was subjected to ammonium
sulfate precipitation (starting with 10% followed by 30% and finally
50%). The pellet after the 50% ammonium sulfate cut was resuspended
in buffer H/0.0 (no salt) and then dialyzed overnight against buffer
H/0.15. The dialyzed sample was then bound to GST beads (Sigma) and
washed three times with buffer H/0.25. Proteins were eluted using
reduced glutathione elution buffer (50 mM Tris/Cl, pH 8.0, 20 mM reduced glutathione, 0.01% Nonidet P-40, 100 mM NaCl). Gel filtration of glutathione eluate using a fast
protein liquid chromatography Superose 12 (Amersham Pharmacia Biotech)
column was performed as described previously (14).
Cell Culture, Transfection, Immunoblotting, Immunoprecipitation,
and Silver Stain--
Sf9 and Hi5 cells were maintained
according to the manufacturers' protocol (Invitrogen). U2OS cells used
for FACS analysis were maintained in Dulbecco's modified Eagle's
medium with 10% fetal bovine serum (Life Technologies, Inc.). Plasmid
DNA used for transfection were purified using Qiagen maxiprep kits.
Cells were grown in 100-mm dishes and transfected using LipofectAMINE (Life Technologies, Inc.). Western blotting and immunoprecipitation techniques were carried out using standard protocols. Anti-GST polyclonal antibodies were purchased from Santa Cruz Biotechnologies. Antibodies against HsORC1-6 have been described previously (9-11, 14). The silver stain method has been described elsewhere (19).
In Vitro Transcription and Translation Reactions and GST
Pull-down Assay--
In vitro transcription and translation
reactions to produce [35S]methionine-labeled full-length
and different deletions of ORC3 were performed using the Promega TNT
system (Madison, WI). Pull-down assays on glutathione-agarose beads
were done as described previously (20).
FACS Analysis--
U2OS cells were transfected with farnesylated
GFP (CLONTECH) alone or in combination with
FLAGORC2, GFPC1-ORC3N, or GFPC1-ORC3C1. Forty-eight hours after
transfection, cells were trypsinized, washed with phosphate-buffered
saline, fixed with cold 70% ethanol, and stored until further use.
Before analysis, fixed cells were resuspended in phosphate-buffered
saline containing 50 µg/ml propidium iodide (Sigma), 10 µg/ml
RNaseA (Sigma), and 0.05% Noniodet P-40 and then incubated for 1 h at 4 °C. Finally cells were washed in phosphate-buffered saline
and analyzed by flow cytometry. The data were further analyzed using
FLOWJO software to calculate the percentage of cells residing in
different cell cycle stages.
GSTORC5, -2, -3, and -4 Forms a Complex--
ORC2, -3, -4, and -5 subunits have been shown to interact with each other in human
cell extracts (14). In an attempt to purify recombinant six protein
human origin recognition complex, we infected Sf9 insect cells
with baculoviruses expressing human ORC1-6 subunits. One of the
subunits, ORC5, was GST-tagged. After pull down on glutathione beads,
we found that GSTORC5, -2, -3, and -4 can be purified as a complex
(Fig. 1A). ORC1 did not enter into the complex in a stoichiometric ratio, and the presence of very
little ORC1 in Fig. 1A was not reproducible in different preparations. ORC6 did not enter into the complex at all. Both ORC1 and
ORC6 were expressed at a high level. In a control experiment, we
expressed GST alone with other ORC subunits. Pull down on glutathione beads purified only GST but none of the ORC subunits. Therefore, the
results in Fig. 1A are due to the formation of a complex of ORC2, -3, -4, and -5 and not due to precipitation of the proteins on
the glutathione beads. GST pull-down experiments using GST tags on
different ORC subunits (GSTORC2 and GSTORC4) confirmed the previous
result showing ORC2, -3, -4, and -5 form a core complex (data not
shown).
To further show that GSTORC5, -2, -3, and -4 subunits are in one
complex, we analyzed the elution pattern of these proteins upon gel
filtration. Proteins were eluted from the GST beads using reduced
glutathione and subsequently passed through a Superose 12 gel
filtration column. Upon Western blotting of different fractions with
different anti-ORC antibodies, we found that GSTORC5, -2, -3, and -4 subunits were co-eluted in one fraction (Fig. 1C). The
molecular mass of this complex is ~500 kDa, which is more than the
combined molecular mass of the four ORC subunits. This may be because
of the multimerization of the GST moieties to give a high molecular
mass complex or because the complex has an atypical shape. Silver
staining of the purified protein used for the gel filtration experiment
indicated that GST-ORC5, ORC2, -3, and -4 were the only proteins
present in the preparation in significant amounts (Fig.
1D).
ORC2 and ORC3 Physically Interact with Each Other--
We were
interested in seeing which of the four interacting subunits interact
directly. Sf9 insect cells were infected with six different
combinations of baculoviruses expressing two ORC subunits in each case.
One of the two viruses was GST-tagged. Affinity purification on
glutathione beads showed that only ORC2 and ORC3 directly interacted
with each other (Fig. 2). None of the
other dual combinations of baculovirus showed any interaction under our
experimental conditions. Therefore, we conclude that ORC2 and ORC3 form
a core component of the ORC2, -3, -4, -5 complex.
ORC2 and ORC3 Recruit ORC4 and -5--
The ORC2-3 complex is
expected to recruit ORC4 and ORC5. We were interested in seeing whether
ORC2-3 core complex can recruit ORC4 first, followed by ORC5, or vice
versa. Sf9 cells were infected by baculoviruses expressing
GSTORC4, -2, and -3 subunits or by viruses expressing GSTORC5, -2, and
-3. GSTORC4 did not interact with ORC2 and ORC3, whereas GSTORC5
interacted with ORC2 and ORC3 (Fig. 3).
Therefore, ORC2-3 core complex is capable of recruiting ORC5, but it
cannot recruit ORC4 by itself. The fact that ORC2, -3, -4, and -5 form
a complex suggests that ORC2, -3, and -5 complex is necessary to load
ORC4. It is also possible that ORC4 and ORC5 can be loaded on ORC2-3
core complex simultaneously independent of each other, but ORC5 is
necessary to stabilize the association of ORC4 with the other ORC
subunits.
N-terminal Portion of ORC3 Interacts with the C-terminal Portion of
ORC2--
Upon establishing the fact that ORC2 and ORC3 form a core
complex, we mapped the interacting domains of ORC2 and ORC3. N-terminal fragments of ORC3 labeled with [35S]methionine were
produced by in vitro transcription and translation in rabbit
reticulocyte lysate. The proteins were incubated with bacterially
expressed and purified GSTORC2 protein. Three polypeptides derived from
ORC3 were capable of binding GSTORC2, whereas the control GST protein
did not bind any of them (Fig.
4A). The smallest fragment
that bound to ORC2 contained 200 amino acids from the N terminus of
ORC3 (construct 3, ORC3N). To map the portion of ORC2
involved in the interaction with ORC3, we expressed and purified GSTORC2C, containing the C-terminal 225 amino acids of ORC2. Both full-length ORC3 and ORC3N bound to GSTORC2C (Fig. 4B),
whereas control GST alone did not bind to any one of them (data not
shown). Therefore, the C-terminal 225 residues of ORC2 interact with
the N-terminal 200 residues of ORC3 to form the ORC2-3 complex at the
core of human ORC. In the reciprocal deletion, removal of the
first 200 amino acids of ORC3 abolished its ability to bind to GSTORC2
(Fig. 4C). Based on these results we conclude that N-terminal 200 residues of ORC3 are necessary and sufficient to interact with ORC2.
N-terminal 200 Amino Acids of ORC3 Can Compete with the Full-length
ORC3--
If the N-terminal 200 residues of ORC3 are sufficient for
binding ORC2, ORC3N might be able to compete with full-length
ORC3 for binding to GSTORC2. [35S]Methionine-labeled ORC3
was bound to GSTORC2 beads under conditions where the latter was
limiting. These beads were then incubated with increasing amounts of
ORC3N. We found that ORC3N protein could compete with the full-length
ORC3 protein for association with GSTORC2 (Fig.
5).
ORC3N Cannot Form a Complex That Contains ORC4-5--
Next we
asked whether ORC3N is capable of mediating the interaction of ORC2
with ORC4 and ORC5. Sf9 insect cells were infected with
baculoviruses expressing GSTORC5, ORC2, ORC4, and ORC3N. After affinity
purification on glutathione beads and Western blotting, we confirmed
the presence of GSTORC5 in the eluate from the beads. Interestingly, in
contrast to the result in Fig. 1A, none of the other ORC
subunits came down with GSTORC5, although they were all present in the
input lane at reasonable quantities (Fig.
6A). We confirmed the physical
interaction between ORC2 and ORC3N in the insect cell lysates by
co-immunoprecipitation reactions. The lysate was immunoprecipitated
using either anti-ORC2 or anti-ORC3 antibodies followed by
immunoblotting with both the antibodies. ORC2 was detected in anti-ORC3
immunoprecipitate and vice versa (Fig. 6B). Therefore, ORC3N
is capable of interacting with ORC2, but this interaction was not
sufficient for further binding of ORC4 and ORC5. The C-terminal portion
of ORC3 appears to be crucial for binding of ORC4 and ORC5 subunits to
ORC2-3 subcomplex.
Expression of ORC3N in U2OS Cells Causes Cell Cycle
Arrest--
Because ORC3N did not form a complex with ORC4 and ORC5
but still could interact with ORC2, we reasoned that ORC3N might show a
dominant negative effect on the cell cycle if overexpressed in a human
cancer cell line. ORC3N and ORC3C1 were cloned into GFPC1
(CLONTECH) expression vector to produce
non-farnesylated GFP fusion proteins. U2OS cells were transfected with
plasmids expressing farnesylated GFP alone or in combination with
FLAGORC2 or GFPORC3N or GFPORC3C1 (1:3 molar ratio) followed by FACS
analysis after 48 h. Cells transfected with GFP alone, FLAG-ORC2,
or GFP-ORC3C1 showed normal cell cycle progression, whereas cells
transfected with GFP-ORC3N were blocked mostly in G1 (73%)
(Fig. 7). This is the first evidence for
any cell cycle effect of any human ORC protein. Since ORC3N can still
bind ORC2 but not ORC4 and ORC5, it is possible that over-expressed
ORC3N interacts with ORC2 but prevents functional ORC formation.
Consistent with this, over-expression of full-length ORC3, which
interacts with ORC2 but allows functional ORC formation, did not block
the cells in G1 (data not shown).
We report here that human ORC2, -3, -4, and -5 form a core complex
in baculovirus-infected insect cells. ORC1 and ORC6 did not interact
with this core complex under these experimental conditions. This was
confirmed by using different tags on different ORC subunits and is
consistent with our previously published data showing that endogenous
ORC2, -3, -4, and -5 in a HeLa cell extract physically interacted with
each other but not with ORC1 and -6(14). Recently ORC1 has been shown
to interact with ORC2 by co-immunoprecipitation reaction using high
salt nuclear lysate from HeLa cells (21). This study did not include
ORC3-6 proteins. Unfortunately, we could not reproduce the
co-immunoprecipitation of ORC1 with ORC2 in human cell lines using two
different ORC1 antibodies, raised independently. Under the same
conditions we still found strong interaction among ORC2-5 subunits.
The data from HeLa cell extract and recombinant baculovirus proteins
strongly suggest that ORC2-5 form a core complex with ORC1 and
ORC6, joining the complex either at very restricted times or locations
or in a very labile interaction that is easily disrupted upon cell lysis.
We further found that ORC2 and ORC3 form a tight complex
essential for binding ORC4 and ORC5. Gel filtration of 293T cell extract showed that ORC2 and 3 were the only two subunits that mostly
co-eluted, consistent with the direct interaction between ORC2 and -3 reported here (16). Under our experimental conditions, none of the
other ORC subunits interact with each other directly. The N-terminal
200 amino acids of ORC3 were enough to interact with C-terminal portion
of ORC2 but not sufficient to allow association with ORC4 and ORC5,
suggesting that the C-terminal of ORC3 is required for ORC4 and ORC5
loading on ORC2-3 subcomplex.
Recently, in yeast S. cerevisiae, ORC2 and ORC3 have been
shown to interact directly (22). Insect cells were infected with baculoviruses expressing yeast ORCs, and recombinant yeast ORC was
purified and tested for its DNA binding ability. ORC6 was found
dispensable for DNA binding property. Elimination of ORC3 during
baculovirus infection led to formation of ORC sub-complex without the
presence of ORC2, suggesting that yeast ORC3 recruits ORC2 to the
complex. Likewise, yeast ORC4 and ORC5 were shown to interact with each
other. In addition, when yeast ORC was bound to yeast ARS1, ORC1, -2, -4, and -5 subunits were shown to directly contact ARS1 DNA by UV
cross-linking (22). The human ORC2-5 sub-complex, however, did not
show any sequence-specific DNA binding activity (data not shown).
Finally we showed that ORC3N has a dominant negative effect on cell
cycle progression. U2OS cells expressing the same fragment were blocked
in G1, whereas the ORC3C1 or ORC2 protein did not prevent
the cells from normal cell cycle progression. This can be explained by
the fact that ORC3N titrates out ORC2 or an unknown cellular protein in
the cell, thereby blocking G1-S transition. Given that ORC2
and ORC3N form a very tight complex but the latter cannot support ORC2,
-3, -4, -5 complex formation, we believe that ORC2 is the target that
is titrated out by ORC3N. We cannot, however, overcome the effect of
ORC3N by over-expressing ORC2 or
ORC2C.2 ORC2 or ORC2C might
not be expressed at high enough levels to titrate out the ORC3N.
Alternatively, the ORC3N targets an unknown cellular factor to cause
the G1-S block.
Based on these results we propose a molecular architecture of human ORC
(Fig. 8). ORC2 and ORC3 interact directly
with the C terminus of the former subunit, in close proximity with the N terminus of the latter. This binding favors the loading of ORC4 and
-5 subunits via the C-terminal residues of ORC3. Although none of the
other ORC subunits interacted with each other, we cannot rule out weak
inter-subunit interactions among themselves. Further experiments will
address how the ORC2-5 complex recruits ORC1 and ORC6 to form human
ORC and study how the complex interacts with DNA.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (48K):
[in a new window]
Fig. 1.
Human ORC2-5 co-purify in a complex.
A, Sf9 insect cells were infected with baculoviruses
expressing ORC1, -2, -3, -4, -6 and GSTORC5. Proteins were purified as
described under "Materials and Methods." Both purified proteins and
crude lysate (Input) were immunoblotted using ORC1-6
antibodies. B, Sf9 insect cells were infected the
same way as in A using baculoviruses expressing ORC2-5 and
GST as control. The cell lysate was purified on GST beads and
immunoblotted. C, Sf9 insect cells were infected with
baculoviruses expressing ORC2, -3, -4 and GST-ORC5. Proteins purified
on GST beads were fractionated on a Superose 12 gel filtration column.
Alternate fractions were immunoblotted using anti-ORC2, -3, -4 and
anti-GST antibodies. The positions of the molecular mass markers
thyroglobulin (670 kDa), bovine gamma globulin (158 kDa), and chicken
ovalbumin (44 kDa) are shown on top. Input lanes were loaded
with 5% of the total lysate passed through the column.

View larger version (49K):
[in a new window]
Fig. 2.
Direct interaction between ORC2 and ORC3
subunits. Sf9 insect cells were infected with six different
combinations of baculoviruses expressing two ORC subunits in each case
(GSTORC2-3 (GSTO2+03), GSTORC5-3 (GSTO5+03),
GSTORC5-4 (GSTO5+04), GSTORC5-2 (GSTO5+02),
GSTORC4-2 (GSTO4+02), and GSTORC4-3 (GSTO4+03)).
Proteins bound to GST beads were immunoblotted using either anti-GST
antibody or respective anti-ORC antibodies. 5% of the total lysate was
loaded in the input lanes.

View larger version (42K):
[in a new window]
Fig. 3.
ORC2-3 subcomplex can load ORC5 but not
ORC4. Sf9 insect cells were infected either with
baculoviruses expressing GSTORC5-2-3 (GSTORC5+2+3) or
baculoviruses expressing GSTORC4-2-3 (GSTORC4+2+3). Proteins
bound to GST beads were immunoblotted using either anti-GST antibodies
or respective anti-ORC antibodies. Input (Inp.)
lane contains 5% of proteins input on GST beads.

View larger version (40K):
[in a new window]
Fig. 4.
Mapping domains of interactions between ORC2
and ORC3. A, full-length ORC3 or different N-terminal
deletions of ORC3 were produced using in vitro transcription
and translation reactions and tested for their ability to bind either
GST or GSTORC2 in a pull-down experiment on glutathione-agarose beads
coated with GST, GSTORC2 (GSTO2). In each case, the input
lanes were loaded with 5% of the amount of the labeled
protein incubated with the beads. The labeled proteins were visualized
by SDS-polyacrylamide gel electrophoresis followed by fluorography.
B, GST pull-down experiment as in A using
GSTORC2C (C-terminal portion of ORC2) and in vitro
transcribed and translated full-length ORC3 (1) or ORC3N200
(3). C, full-length ORC3 or different C-terminal
deletions of ORC3 were produced using in vitro transcription
translation reaction. GST pull-down experiments were performed as shown
in Fig. 5A using either GST or GSTORC2.

View larger version (61K):
[in a new window]
Fig. 5.
ORC3N can compete with full-length ORC3.
GSTORC2 beads were incubated with in vitro transcribed and
translated full-length ORC3. After incubation, beads were thoroughly
washed using binding buffer and incubated again with increasing amount
of in vitro transcribed and translated ORC3N200. Beads were
finally washed, and bound labeled proteins were visualized by
SDS-polyacrylamide gel electrophoresis followed by fluorography.

View larger version (39K):
[in a new window]
Fig. 6.
ORC3N does not form a complex with ORC2, -4, and -5. A, Sf9 insect cells were infected with
baculoviruses expressing GSTORC5, -2, -4 and ORC3N200. Proteins bound
to glutathione-agarose beads were immunoblotted using either anti-GST
or anti-ORC antibodies. B, immunoprecipitation using
anti-ORC2 and anti-ORC3 antibodies. Insect cell lysate from
A was immunoprecipitated (IP) using either
anti-ORC2 or anti-ORC3 antibodies followed by immunoblotting
(IB) with either anti-ORC3 or anti-ORC2 antibodies. In
each case 5% of the lysate (used for immunoprecipitation) was loaded
in the input (Inp) lanes. Sera used for
immunoprecipitation: I, immune, and PI,
preimmune.

View larger version (24K):
[in a new window]
Fig. 7.
FACS analysis of U2OS cells transfected with
different constructs. U2OS cells were transfected either with
farnesylated GFP (CLONTECH) or in combination with
FLAGORC2, GFPORC3N, or GFPORC3C1. Transfected cells were fixed and
stained with propidium iodide and then analyzed by FACS. The percentage
of cell population present at different cell cycle stages in each
transfection is shown at the bottom of the each
panel.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (14K):
[in a new window]
Fig. 8.
Model of human ORC2-5 subcomplex. Human
ORC subunits are showed as numbers 1-6. ORC2-5 subunits are shown to
form a complex. N and C in ORC2 and -3 depict N- and C-terminal
residues of the individual subunits. The arrow with the
bold line shows a strong interaction, whereas
arrows with dotted lines indicate weak
interactions.
| |
ACKNOWLEDGEMENTS |
|---|
We acknowledge David Garcia Quintana, Anjali Satoshkar, and Zhi Hui Hou for making the baculovirus constructs and J. Wohlschlegel for help with the analysis of the FACS data.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Grant CA60499 (to A. D.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by United States Army Postdoctoral Fellowship
DAMD17-00-1-0166.
§ Supported by the American Cancer Society Postdoctoral Fellowship PF-99-328-01-CCG.
¶ To whom correspondence should be addressed: Dept. of Pathology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston MA 02115. Tel.: 617-278-0468; Fax: 617-732-7449; E-mail: adutta@rics.bwh.harvard.edu.
Published, JBC Papers in Press, June 6, 2001, DOI 10.1074/jbc.M103078200
2 S. K. Dhar and A. Dutta, unpublished information.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: ORC, origin recognition complex; GST, glutathione S-transferase; FACS, fluorescence-activated cell sorter; GFP, green fluorescent protein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bell, S. P., and Stillman, B. (1992) Nature 357, 128-134 |
| 2. | Dutta, A., and Bell, S. P. (1997) Annu. Rev. Cell Dev. Biol. 13, 293-332 |
| 3. | Kelly, T. J., and Brown, G. W. (2000) Annu. Rev. Biochem. 69, 829-880 |
| 4. | Rowles, A., Chong, J. P., Brown, L., Howell, M., Evan, G. I., and Blow, J. J. (1996) Cell 87, 287-296 |
| 5. | Gossen, M., Pak, D. T., Hansen, S. K., Acharya, J. K., and Botchan, M. R. (1995) Science 270, 1674-1677 |
| 6. | Moon, K. Y., Kong, D., Lee, J. K., Raychaudhuri, S., and Hurwitz, J. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 12367-12372 |
| 7. | Gavin, K. A., Hidaka, M., and Stillman, B. (1995) Science 270, 1667-1671 |
| 8. | Takahara, K., Bong, M., Brevard, R., Eddy, R. L., Haley, L. L., Sait, S. J., Shows, T. B., Hoffman, G. G., and Greenspan, D. S. (1996) Genomics 31, 119-122 |
| 9. | Pinto, S., Quintana, D. G., Smith, P., Mihalek, R. M., Hou, Z. H., Boynton, S., Jones, C. J., Hendricks, M., Velinzon, K., Wohlschlegel, J. A., Austin, R. J., Lane, W. S., Tully, T., and Dutta, A. (1999) Neuron 23, 45-54 |
| 10. | Quintana, D. G., Hou, Z., Thome, K. C., Hendricks, M., Saha, P., and Dutta, A. (1997) J. Biol. Chem. 272, 28247-28251 |
| 11. | Quintana, D. G., Thome, K. C., Hou, Z. H., Ligon, A. H., Morton, C. C., and Dutta, A. (1998) J. Biol. Chem. 273, 27137-27145 |
| 12. | Tugal, T., Zou-Yang, X. H., Gavin, K., Pappin, D., Canas, B., Kobayashi, R., Hunt, T., and Stillman, B. (1998) J. Biol. Chem. 273, 32421-32429 |
| 13. | Ishiai, M., Dean, F. B., Okumura, K., Abe, M., Moon, K. Y., Amin, A. A., Kagotani, K., Taguchi, H., Murakami, Y., Hanaoka, F., O'Donnell, M., Hurwitz, J., and Eki, T. (1997) Genomics 46, 294-298 |
| 14. | Dhar, S. K., and Dutta, A. (2000) J. Biol. Chem. 275, 34983-34988 |
| 15. | Natale, D. A., Li, C. J., Sun, W. H., and DePamphilis, M. L. (2000) EMBO J. 19, 2728-2738 |
| 16. | Thome, K. C., Dhar, S. K., Quintana, D. G., Delmolino, L., Shahsafaei, A., and Dutta, A. (2000) J. Biol. Chem. 275, 35233-35241 |
| 17. | Chesnokov, I., Gossen, M., Remus, D., and Botchan, M. (1999) Genes Dev. 13, 1289-1296 |
| 18. | Austin, R. J., Orr-Weaver, T. L., and Bell, S. P. (1999) Genes Dev. 13, 2639-2649 |
| 19. | Dunn, M. J., and Crisp, S. J. (1994) Methods Mol. Biol. 32, 113-118 |
| 20. | Lin, Y. L., Chen, C., Keshav, K. F., Winchester, E., and Dutta, A. (1996) J. Biol. Chem. 271, 17190-17198 |
| 21. | Kreitz, S., Ritzi, M., Baack, M., and Knippers, R. (2000) J. Biol. Chem. 276, 6337-6342 |
| 22. | Lee, D. G., and Bell, S. P. (1997) Mol. Cell. Biol. 17, 7159-68 |
This article has been cited by other articles:
![]() |
K. Siddiqui and B. Stillman ATP-dependent Assembly of the Human Origin Recognition Complex J. Biol. Chem., November 2, 2007; 282(44): 32370 - 32383. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Minami, J. Takahashi, A. Suto, Y. Saitoh, and K.-i. Tsutsumi Binding of AlF-C, an Orc1-Binding Transcriptional Regulator, Enhances Replicator Activity of the Rat Aldolase B Origin Mol. Cell. Biol., December 1, 2006; 26(23): 8770 - 8780. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Radichev, S. W. Kwon, Y. Zhao, M. L. DePamphilis, and A. Vassilev Genetic Analysis of Human Orc2 Reveals Specific Domains That Are Required in Vivo for Assembly and Nuclear Localization of the Origin Recognition Complex J. Biol. Chem., August 11, 2006; 281(32): 23264 - 23273. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Baltin, S. Leist, F. Odronitz, H.-P. Wollscheid, M. Baack, T. Kapitza, D. Schaarschmidt, and R. Knippers DNA Replication in Protein Extracts from Human Cells Requires ORC and Mcm Proteins J. Biol. Chem., May 5, 2006; 281(18): 12428 - 12435. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saha, S. Ghosh, A. Vassilev, and M. L. DePamphilis Ubiquitylation, phosphorylation and Orc2 modulate the subcellular location of Orc1 and prevent it from inducing apoptosis J. Cell Sci., April 1, 2006; 119(7): 1371 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ranjan and M. Gossen A structural role for ATP in the formation and stability of the human origin recognition complex PNAS, March 28, 2006; 103(13): 4864 - 4869. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Teer, Y. J. Machida, H. Labit, O. Novac, O. Hyrien, K. Marheineke, M. Zannis-Hadjopoulos, and A. Dutta Proliferating Human Cells Hypomorphic for Origin Recognition Complex 2 and Pre-replicative Complex Formation Have a Defect in p53 Activation and Cdk2 Kinase Activation J. Biol. Chem., March 10, 2006; 281(10): 6253 - 6260. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Takeda, Y. Shibata, J. D. Parvin, and A. Dutta Recruitment of ORC or CDC6 to DNA is sufficient to create an artificial origin of replication in mammalian cells Genes & Dev., December 1, 2005; 19(23): 2827 - 2836. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Huang, K. Zang, and L. F. Reichardt The origin recognition core complex regulates dendrite and spine development in postmitotic neurons J. Cell Biol., August 15, 2005; 170(4): 527 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sibani, G. B. Price, and M. Zannis-Hadjopoulos Decreased origin usage and initiation of DNA replication in haploinsufficient HCT116 Ku80+/- cells J. Cell Sci., August 1, 2005; 118(15): 3247 - 3261. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Machida, J. K. Teer, and A. Dutta Acute Reduction of an Origin Recognition Complex (ORC) Subunit in Human Cells Reveals a Requirement of ORC for Cdk2 Activation J. Biol. Chem., July 29, 2005; 280(30): 27624 - 27630. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miyake, T. Mizuno, K.-i. Yanagi, and F. Hanaoka Novel Splicing Variant of Mouse Orc1 Is Deficient in Nuclear Translocation and Resistant for Proteasome-mediated Degradation J. Biol. Chem., April 1, 2005; 280(13): 12643 - 12652. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Giordano-Coltart, C. Y. Ying, J. Gautier, and J. Hurwitz Studies of the properties of human origin recognition complex and its Walker A motif mutants PNAS, January 4, 2005; 102(1): 69 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Stedman, Z. Deng, F. Lu, and P. M. Lieberman ORC, MCM, and Histone Hyperacetylation at the Kaposi's Sarcoma-Associated Herpesvirus Latent Replication Origin J. Virol., November 15, 2004; 78(22): 12566 - 12575. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ramachandran, E. Hainsworth, B. Bhullar, S. Eisenstein, B. Rosen, A. Y. Lau, J. C. Walter, and J. LaBaer Self-Assembling Protein Microarrays Science, July 2, 2004; 305(5680): 86 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-j. Li, A. Vassilev, and M. L. DePamphilis Role for Cdk1 (Cdc2)/Cyclin A in Preventing the Mammalian Origin Recognition Complex's Largest Subunit (Orc1) from Binding to Chromatin during Mitosis Mol. Cell. Biol., July 1, 2004; 24(13): 5875 - 5886. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Collinge, C. Spillane, C. Kohler, J. Gheyselinck, and U. Grossniklaus Genetic Interaction of an Origin Recognition Complex Subunit and the Polycomb Group Gene MEDEA during Seed Development PLANT CELL, April 1, 2004; 16(4): 1035 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tatsumi, S. Ohta, H. Kimura, T. Tsurimoto, and C. Obuse The ORC1 Cycle in Human Cells: I. CELL CYCLE-REGULATED OSCILLATION OF HUMAN ORC1 J. Biol. Chem., October 17, 2003; 278(42): 41528 - 41534. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohta, Y. Tatsumi, M. Fujita, T. Tsurimoto, and C. Obuse The ORC1 Cycle in Human Cells: II. DYNAMIC CHANGES IN THE HUMAN ORC COMPLEX DURING THE CELL CYCLE J. Biol. Chem., October 17, 2003; 278(42): 41535 - 41540. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vashee, C. Cvetic, W. Lu, P. Simancek, T. J. Kelly, and J. C. Walter Sequence-independent DNA binding and replication initiation by the human origin recognition complex Genes & Dev., August 1, 2003; 17(15): 1894 - 1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Huang and D. Koshland Chromosome integrity in Saccharomyces cerevisiae: the interplay of DNA replication initiation factors, elongation factors, and origins Genes & Dev., July 15, 2003; 17(14): 1741 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R.X. Hickson, J. Matheson, B. Riggs, V. H. Maier, A. B. Fielding, R. Prekeris, W. Sullivan, F. A. Barr, and G. W. Gould Arfophilins Are Dual Arf/Rab 11 Binding Proteins That Regulate Recycling Endosome Distribution and Are Related to Drosophila Nuclear Fallout Mol. Biol. Cell, July 1, 2003; 14(7): 2908 - 2920. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Witmer, R. Alvarez-Venegas, P. San-Miguel, O. Danilevskaya, and Z. Avramova Putative subunits of the maize origin of replication recognition complex ZmORC1-ZmORC5 Nucleic Acids Res., January 15, 2003; 31(2): 619 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Saitoh, S. Miyagi, H. Ariga, and K.-i. Tsutsumi Functional domains involved in the interaction between Orc1 and transcriptional repressor AlF-C that bind to an origin/promoter of the rat aldolase B gene Nucleic Acids Res., December 1, 2002; 30(23): 5205 - 5212. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hu, A. C. Garber, and R. Renne The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Supports Latent DNA Replication in Dividing Cells J. Virol., October 11, 2002; 76(22): 11677 - 11687. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Keller, E.-M. Ladenburger, M. Kremer, and R. Knippers The Origin Recognition Complex Marks a Replication Origin in the Human TOP1 Gene Promoter J. Biol. Chem., August 23, 2002; 277(35): 31430 - 31440. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Bell The origin recognition complex: from simple origins to complex functions Genes & Dev., March 15, 2002; 16(6): 659 - 672. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||